CAESARS ENTERTAINMENT INC (CZR) Fundamental Analysis & Valuation

NASDAQ:CZR • US12769G1004

Current stock price

26.88 USD
+0.44 (+1.66%)
At close:
26.9753 USD
+0.1 (+0.35%)
After Hours:

This CZR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CZR Profitability Analysis

1.1 Basic Checks

  • CZR had negative earnings in the past year.
  • In the past year CZR had a positive cash flow from operations.
  • In the past 5 years CZR reported 4 times negative net income.
  • Each year in the past 5 years CZR had a positive operating cash flow.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • CZR has a worse Return On Assets (-1.59%) than 71.43% of its industry peers.
  • CZR's Return On Equity of -14.33% is on the low side compared to the rest of the industry. CZR is outperformed by 60.32% of its industry peers.
  • CZR has a Return On Invested Capital (5.59%) which is comparable to the rest of the industry.
  • CZR had an Average Return On Invested Capital over the past 3 years of 6.03%. This is below the industry average of 10.55%.
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROIC 5.59%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • With a decent Operating Margin value of 18.09%, CZR is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • CZR's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CZR (47.20%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CZR has grown nicely.
Industry RankSector Rank
OM 18.09%
PM (TTM) N/A
GM 47.2%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1

2. CZR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CZR is still creating some value.
  • CZR has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CZR has less shares outstanding
  • CZR has a worse debt/assets ratio than last year.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that CZR is in the distress zone and has some risk of bankruptcy.
  • CZR's Altman-Z score of 0.53 is on the low side compared to the rest of the industry. CZR is outperformed by 75.40% of its industry peers.
  • CZR has a debt to FCF ratio of 50.47. This is a negative value and a sign of low solvency as CZR would need 50.47 years to pay back of all of its debts.
  • CZR's Debt to FCF ratio of 50.47 is on the low side compared to the rest of the industry. CZR is outperformed by 61.90% of its industry peers.
  • A Debt/Equity ratio of 7.07 is on the high side and indicates that CZR has dependencies on debt financing.
  • The Debt to Equity ratio of CZR (7.07) is worse than 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Altman-Z 0.53
ROIC/WACC1.12
WACC4.97%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • CZR has a Current Ratio of 0.80. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.80, CZR is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
  • CZR has a Quick Ratio of 0.80. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CZR (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.78
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. CZR Growth Analysis

3.1 Past

  • CZR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -228.38%.
  • The Revenue has been growing slightly by 2.14% in the past year.
  • The Revenue has been growing by 25.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.63% on average over the next years. This is a very strong growth
  • CZR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.10% yearly.
EPS Next Y93.96%
EPS Next 2Y49.43%
EPS Next 3Y35.21%
EPS Next 5Y30.63%
Revenue Next Year2.82%
Revenue Next 2Y2.63%
Revenue Next 3Y2.51%
Revenue Next 5Y3.1%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 -10

3

4. CZR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CZR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CZR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CZR indicates a somewhat cheap valuation: CZR is cheaper than 79.37% of the companies listed in the same industry.
  • 88.10% of the companies in the same industry are more expensive than CZR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.1
EV/EBITDA 8.43
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

  • CZR's earnings are expected to grow with 35.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.43%
EPS Next 3Y35.21%

0

5. CZR Dividend Analysis

5.1 Amount

  • CZR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CZR Fundamentals: All Metrics, Ratios and Statistics

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (4/10/2026, 8:15:32 PM)

After market: 26.9753 +0.1 (+0.35%)

26.88

+0.44 (+1.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners111.94%
Inst Owner Change0.01%
Ins Owners1.04%
Ins Owner Change3.6%
Market Cap5.47B
Revenue(TTM)11.49B
Net Income(TTM)-502.00M
Analysts77.5
Price Target32.55 (21.09%)
Short Float %13.53%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-513.02%
Min EPS beat(2)-639.28%
Max EPS beat(2)-386.76%
EPS beat(4)0
Avg EPS beat(4)-533.78%
Min EPS beat(4)-925.61%
Max EPS beat(4)-183.48%
EPS beat(8)1
Avg EPS beat(8)-434.23%
EPS beat(12)2
Avg EPS beat(12)-1183.03%
EPS beat(16)3
Avg EPS beat(16)-932.06%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)-0.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)5
Avg Revenue beat(16)-0.89%
PT rev (1m)-5.01%
PT rev (3m)-9%
EPS NQ rev (1m)6.55%
EPS NQ rev (3m)-75.65%
EPS NY rev (1m)-86.42%
EPS NY rev (3m)-152.02%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-1.07%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF 11.1
P/OCF 4.2
P/B 1.56
P/tB N/A
EV/EBITDA 8.43
EPS(TTM)-2.43
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)2.42
FCFY9.01%
OCF(TTM)6.4
OCFY23.8%
SpS56.44
BVpS17.22
TBVpS-53.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROCE 7.07%
ROIC 5.59%
ROICexc 5.76%
ROICexgc 11.67%
OM 18.09%
PM (TTM) N/A
GM 47.2%
FCFM 4.29%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
ROICexc(3y)6.22%
ROICexc(5y)5.57%
ROICexgc(3y)12.71%
ROICexgc(5y)11.43%
ROCE(3y)7.63%
ROCE(5y)6.83%
ROICexgc growth 3Y3.82%
ROICexgc growth 5Y91.84%
ROICexc growth 3Y5.32%
ROICexc growth 5Y87.13%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Debt/EBITDA 7.09
Cap/Depr 57.09%
Cap/Sales 7.04%
Interest Coverage 2.56
Cash Conversion 37.25%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.78
Altman-Z 0.53
F-Score5
WACC4.97%
ROIC/WACC1.12
Cap/Depr(3y)86.24%
Cap/Depr(5y)82.51%
Cap/Sales(3y)9.98%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
EPS Next Y93.96%
EPS Next 2Y49.43%
EPS Next 3Y35.21%
EPS Next 5Y30.63%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%
Revenue Next Year2.82%
Revenue Next 2Y2.63%
Revenue Next 3Y2.51%
Revenue Next 5Y3.1%
EBIT growth 1Y-8.66%
EBIT growth 3Y3.74%
EBIT growth 5Y82.73%
EBIT Next Year81.53%
EBIT Next 3Y24.47%
EBIT Next 5Y17.36%
FCF growth 1Y308.9%
FCF growth 3Y245.06%
FCF growth 5YN/A
OCF growth 1Y21.12%
OCF growth 3Y10.12%
OCF growth 5YN/A

CAESARS ENTERTAINMENT INC / CZR Fundamental Analysis FAQ

What is the fundamental rating for CZR stock?

ChartMill assigns a fundamental rating of 2 / 10 to CZR.


Can you provide the valuation status for CAESARS ENTERTAINMENT INC?

ChartMill assigns a valuation rating of 3 / 10 to CAESARS ENTERTAINMENT INC (CZR). This can be considered as Overvalued.


How profitable is CAESARS ENTERTAINMENT INC (CZR) stock?

CAESARS ENTERTAINMENT INC (CZR) has a profitability rating of 3 / 10.